active pharmaceutical ingredients, cdsco, central drugs standard control organisation, cervical cancer prevention, cipla, coronavirus, daiichi sankyo, ebola virus disease, fortis healthcare, glp-1 drugs, glp-1 weight loss drugs, health, hpv vaccine india, ihh healthcare, india drug regulator, journalist, journalists, news, obesity treatment, pharma, pharmaceutical industry, pharmaceutical supply chain, pharmexcil, semaglutide, sun pharma, jackson laboratories, delhi high court, cancer treatment, spurious oxytocin injections, fortis malar hospitals, september 10 verdict, asian corporates, share acquisition, healthcare giant, legal battle, ntk damages claim